- NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer
- MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain
- Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance
- Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company
- NICE RECOMMENDS LILLY’S TIRZEPATIDE (MOUNJARO ®▼) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE
- UCB presents epilepsy research at American Epilepsy Society Annual Meeting
- Gemma Cathcart appointed managing partner at Langland
- Ceryx Medical Initiates First-In-Human Study of the Cysoni™ RSA Pacemaker
- Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens
- Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List
- Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
- Antibacterial peptides instrumental in efficiency against resistant bacteria
- Spinal cord stimulator with AI technology receives CE Mark certification
- J&J seek approval for first drug to treat high-risk smoldering myeloma
- Theramex receives recommendation for YSELTY in Scotland